Product Images Daurismo

This appears to be a numerical data table showing survival probabilities and median overall survival rates for two treatment groups - one using a drug called "DAURISMO" along with low-dose cytarabine and the other using low-dose cytarabine alone. The data suggests that the addition of DAURISMO to the treatment resulted in significantly higher median overall survival rates and lower hazard ratios. The table also includes a graph showing the survival time in months.*

This is a description of a pharmaceutical product or medication that is distributed by Pfizer Labs, which is a subdivision of Pfizer Inc. The specific type or name of the product is not mentioned.*

This text provides information on the distributor of a product, Pfizer Labs, which is a division of the pharmaceutical company, Pfizer Inc, located in New York, NY. It suggests that the product may have been manufactured or developed by Pfizer Labs and is being distributed by the same company.*

This is a medication label for a product containing gastiegh and glasdegib maleate. The medication should be stored between 20°C to 25°C and dispensed only with a medication guide. The tablets should not be cut, crushed, or chewed. The dosage and instructions for use can be found in the accompanying prescribing information. The medication is distributed by Pizer Labs and comes in child-resistant containers. The lot number, expiration date, and GTIN are also provided.*

This is prescription information for Daurismo tablets containing 100mg of glasdegib. The tablets should be stored in child-resistant containers at 20°C to 25°C and dispensed with medication guide. The tablets should not be cut, crushed or chewed. The NDC for this product is 0069-1531-30 and it is distributed by Pfizer Labs.*